LRRK2 & Microtubules

Mutations in the LRRK2 gene are risk-factors for developing Parkinson’s disease (PD). LRRK2 mutations in PD have been shown to enhance its association with microtubules. Here is the latest research.

October 22, 2020

"Opening" New Insights into LRRK2 Conformation and the Microtubule

Movement Disorders : Official Journal of the Movement Disorder Society
Diana A Olszewska, Anthony E Lang
May 24, 2016
Open Access

The entangled ER-mitochondrial axis as a potential therapeutic strategy in neurodegeneration: A tangled duo unchained

Cell Calcium
Amit U JoshiDaria Mochly-Rosen
December 4, 2020
Open Access

Pathological Functions of LRRK2 in Parkinson's Disease

Ga Ram Jeong, Byoung Dae Lee
May 16, 2017
Open Access

Tale of the Good and the Bad Cdk5: Remodeling of the Actin Cytoskeleton in the Brain

Molecular Neurobiology
Kavita Shah, Sandra Rossie
November 10, 2019
Open Access

The in situ structure of Parkinson's disease-linked LRRK2

BioRxiv : the Preprint Server for Biology
Reika WatanabeElizabeth Villa
February 14, 2019
Open Access

Podocytes and autophagy: a potential therapeutic target in lupus nephritis

Xu-Jie ZhouHong Zhang
May 10, 2018
Open Access

Tubulin and Tau: Possible targets for diagnosis of Parkinson's and Alzheimer's diseases

PloS One
Mohamed SalamaMohamed B Abou Donia
March 30, 2017

Mechanisms of Mutant LRRK2 Neurodegeneration

Advances in Neurobiology
Mark R Cookson
December 26, 2016
Open Access

Altered microtubule dynamics in neurodegenerative disease: Therapeutic potential of microtubule-stabilizing drugs

Neurobiology of Disease
Kurt R BrundenCarlo Ballatore
July 12, 2019
Open Access

The dynamic switch mechanism that leads to activation of LRRK2 is embedded in the DFGψ motif in the kinase domain

Proceedings of the National Academy of Sciences of the United States of America
Sven H. SchmidtFriedrich W. Herberg
April 6, 2019
Open Access

Emerging views of mitophagy in immunity and autoimmune diseases

Ye XuZhihua Ran
August 20, 2020

Structure of LRRK2 in Parkinson's disease and model for microtubule interaction

Colin K DenistonAndres E Leschziner
December 23, 2019
Open Access

LRRK2 Biology from structure to dysfunction: research progresses, but the themes remain the same

Molecular Neurodegeneration
Daniel C BerwickKirsten Harvey
December 22, 2020
Case Report
Open Access

A Specific Diplotype H1j/H2 of the MAPT Gene Could Be Responsible for Parkinson's Disease with Dementia

Case Reports in Genetics
Imane SmailiAhmed Bouhouche
February 17, 2017
Open Access

LRRK2: from kinase to GTPase to microtubules and back

Biochemical Society Transactions
Marian Blanca RamírezSabine Hilfiker
July 1, 2019
Open Access

Neuronal microtubules and proteins linked to Parkinson's disease: a relevant interaction?

Biological Chemistry
Alessandra M CalogeroGraziella Cappelletti
July 14, 2020
Open Access

Conformation and dynamics of the kinase domain drive subcellular location and activation of LRRK2

BioRxiv : the Preprint Server for Biology
Sven H. SchmidtSusan S. Taylor
July 2, 2016

LRRK2 interferes with aggresome formation for autophagic clearance

Molecular and Cellular Neurosciences
Yeojin BangHyun Jin Choi
November 24, 2018
Open Access

The role of LRRK2 in cytoskeletal dynamics

Biochemical Society Transactions
Laura CivieroElisa Greggio

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.


TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2021 Meta ULC. All rights reserved